🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSemaglutide (Ozempic / Wegovy)Can I drink on sema or will I die — need advice

Can I drink on sema or will I die — need advice

Dr.LeslieOBGYN Wed, Jan 24, 2024 at 4:47 AM 14 replies 2,106 viewsPage 1 of 3
This thread is more than 28 months old. Information may be outdated. Consider searching for more recent discussions.
Dr.LeslieOBGYN
Member
567
2,567
May 2024
Dallas, TX
Jan 24, 2024 at 4:47 AM#1

I moved from brand to compounded semaglutide at the same nominal dose and cannot decide whether what changed is the material, my titration, or my expectations.

What would genuinely help is knowing whether anyone has held at a sub-maximal dose long term and kept the result, or whether the maintenance data only exists at 2.4mg.

Not looking for reassurance. Looking for the part I have got wrong.

17 12Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 14 others
Reply Quote Save Share Report
LibrarianMeg
Senior Member
1,678
7,890
Mar 2024
Baltimore, MD
Jan 24, 2024 at 5:08 AM#2

Taking the question as asked, rather than the general version of it. The mechanism that matters here is not stomach emptying, it is central. GLP-1 receptor agonism in the arcuate nucleus stimulates POMC neurons and suppresses AgRP/NPY signalling, which is why the effect is appetite and food salience rather than physical fullness. Delayed gastric emptying largely tachyphylaxes over the first months; the appetite effect does not.

That is the short version; the long version is somebody else's post.

16 11PharmD_Rodriguez, julia.endo, JessicaM_2024 and 13 others
Reply Quote Save Share Report
maya_sedona
Member
289
1,234
Sep 2024
Sedona, AZ
Jan 24, 2024 at 5:29 AM#3
LibrarianMeg said:
The mechanism that matters here is not stomach emptying, it is central.

No disagreement with LibrarianMeg. One condition attached. Albumin binding above 99% is the whole reason weekly dosing works, and it is also why the trough matters more than the peak. People who dose late are not losing a peak, they are letting the trough fall, and the appetite effect tracks the trough.

15 10BenResearch_OR, MikeKY_noInsulin, Dr.RaviCardio and 12 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
dan_philly
Member
456
2,123
Jul 2024
Philadelphia, PA
Jan 24, 2024 at 5:50 AM#4
Dr.LeslieOBGYN said:
I moved from brand to compounded semaglutide at the same nominal dose and cannot decide whether what changed is the material, my titration, or my…

Agreed, though "tolerable" needs defining. A dose you tolerate by eating almost nothing is not tolerated, it is being paid for somewhere else — usually in lean mass, sometimes in adherence three months later.

Last edited: Jan 24, 2024 at 8:50 AM
14 9Dr.CardioMD, EndoResFellow, PharmacoVig_BOS and 11 others
Reply Quote Save Share Report
Dr.CardioMD
VIP Member
2,678
14,567
Dec 2023
Cleveland, OH
Jan 24, 2024 at 7:45 AM#5

Clinical perspective, offered as context rather than as advice.

Dr.LeslieOBGYN said:
...but the FDA says semaglutide...

Interesting point. I want to add some regulatory nuance: the FDA labeling reflects the specific clinical trial data submitted for approval. Real-world clinical practice often extends beyond the FDA label based on emerging evidence and clinical judgment.

Example: semaglutide was first approved for diabetes (Ozempic), then obesity (Wegovy). The molecule didn't change — our understanding of its applications expanded. Similarly, semaglutide may evolve as more data accumulates.

13 8josh_phd_bmore, roxy_nash, tony_orlando and 10 others
Reply Quote Save Share Report

Similar Threads

STEP 1-5 trials comprehensive summary — efficacy endpoints compiled12 replies
Oral semaglutide 50mg Phase 3 — OASIS program results16 replies
Semaglutide pharmacokinetics — half-life, Tmax, steady state modeling10 replies
Compounded semaglutide stability data — temperature and light sensitivity16 replies
0.25mg → 2.4mg titration: optimal schedule based on clinical data6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register